Entity
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10

infinite
0
| InterPro | IPR000157 |
| TRANSPATH | MO000016573 |
--
fibrinogen
--
MO000017426
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2254
10

infinite
0
| TRANSPATH | MO000017426 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6255
10

infinite
0
| TRANSPATH | MO000021929 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10

infinite
0
| TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0

infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0

infinite
0
--
Mal
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0

infinite
0
--
ssRNA
--
e13
cso30:c:Rna
cso30:i:CC_Extracellular
--
csml-variable:Double
m13
0

infinite
0
--
ssRNA: TLR7
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m14
0

infinite
0
--
ssRNA: TLR8
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m15
0

infinite
0
--
CpG DNA
--
e16
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m16
0

infinite
0
--
CpG DNA: TLR9
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m17
0

infinite
0
--
LPS:LBP:CD14: TLR4: MD2: Mal: MyD88
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0

infinite
0
--
LTA
--
e19
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m19
0

infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0

infinite
0
--
LTA: TLR1: TLR2
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0

infinite
0
--
LTA:TLR1: TLR2: Mal: MyD88
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0

infinite
0
--
TLR1: TLR2
--
e22
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m22
0

infinite
0
--
TLR6: TLR2
--
e23
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m23
0

infinite
0
--
LTA: TLR6: TLR2
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m24
0

infinite
0
--
LTA:TLR6: TLR2: Mal: MyD88
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m25
0

infinite
0
--
FSL-1
--
e26
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m26
0

infinite
0
--
Pam3CSK4: TLR1: TLR2
--
e27
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m27
0

infinite
0
--
Pam3CSK4
--
e29
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m29
0

infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0

infinite
0
--
LPS:LBP:CD14: TLR4: MD2: TRAM: TRIF
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m30
0

infinite
0
--
FSL-1: TLR6: TLR2
--
e31
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m31
0

infinite
0
--
IRAK{p}
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0

infinite
0
--
TRAF6 {activated}
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m33
10

infinite
0
| InterPro | IPR001841 |
| TRANSPATH | MO000000212 |
--
NF-kappaB {activated}
--
e34
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m35
10

infinite
0
| TRANSPATH | MO000000058 |
--
COX-2
--
e35
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m36
0

infinite
0
--
endothelin-1
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m37
0

infinite
0
--
csml-variable:Double
m38
10

infinite
0
| Affymetrix | 104420_at |
| Ensembl | ENSMUSG00000020826 |
| MGD | Nos2 |
| Proteome | HumanPSD/Nos2 |
| RefSeq | NM_010927 |
| TRANSFAC | G001073 |
| Unigene | Mm.2893 |
--
R-MALP2
--
e38
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m39
0

infinite
0
--
R_MALP2: TLR6: TLR2
--
e39
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m40
0

infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0

infinite
0
--
PepG
--
e40
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m41
0

infinite
0
--
PepG: NOD1
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0

infinite
0
--
PepG: NOD2
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0

infinite
0
--
PepG: NOD2: RIP2
--
e43
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m44
0

infinite
0
--
PepG: NOD1: RIP2
--
e44
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m45
0

infinite
0
--
Caspase-1 [activated}
--
e45
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m46
10

infinite
0
| TRANSPATH | MO000016828 |
--
IL-8
--
e46
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m47
0

infinite
0
--
dsRNA:TLR3: TRIF
--
e47
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m48
0

infinite
0
--
ssRNA: TLR7: MyD88
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m49
0

infinite
0
--
ssRNA: TLR8: MyD88
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m63
0

infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0

infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0

infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0

infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0

infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0

infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0

infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0

infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0

infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0

infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0

infinite
0
--
LPS:LBP:CD14: TLR4: MD2
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0

infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0

infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0

infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0

infinite
0
--
TLR
--
e63
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m64
0

infinite
0
--
HSP
--
e64
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m65
0

infinite
0
--
TLR: HSP
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m66
0

infinite
0
--
hyaluronic acid
--
e66
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m67
0

infinite
0
--
hyaluronic acid: TLR
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m68
0

infinite
0
--
soluble heparan sulphate
--
e68
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m69
0

infinite
0
--
soluble heparan sulphate: TLR
--
e69
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m70
0

infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0

infinite
0
--
fibrinogen: TLR
--
e70
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m71
0

infinite
0
--
LDL: TLR
--
e71
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m72
0

infinite
0
--
beta-defensin 2
--
e72
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m73
0

infinite
0
--
beta-defensin 2: TLR
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0

infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0

infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0

infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c3 : 1
stoichiometry:c2 : 1
m155666*m3985*0.1
nodelay
--

0

PMID: 17535871, 2402637 LBP binds to the amphipathic lipid A moiety of LPS and facilitates its presentation and transfer to CD14.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c41 : 1
stoichiometry:c79 : 1
stoichiometry:c31 : 1
m19*m22*m2828*0.1
nodelay
--

0

PMID: 17535871 LTA from Gram-positive bacteria is sensed by TLR2. PMID: 17535871, 16880211 while CD36 facilitates TLR2/TLR6 signalling, CD14 enhanced the sensing of ligands by the TLR2/TLR1 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m20*m11*m1572*0.1
nodelay
--

0

PMID: 17535871 TLR2, on the other hand, recruits just MyD88/Mal pathways.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m3987*m3964*0.1
nodelay
--

0

PMID: 17535871, 16880211, 11095740, 10549626 TLR2 is not thought to act as a monomeric receptor, but heterodimerises with either TLR1 or TLR6 to evoke effects.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c48 : 1
stoichiometry:c43 : 1
m19*m23*0.1
nodelay
--

0

PMID: 17535871 LTA from Gram-positive bacteria is sensed by TLR2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c47 : 1
stoichiometry:c46 : 1
m11*m1572*m24*0.1
nodelay
--

0

PMID: 17535871 TLR2, on the other hand, recruits just MyD88/Mal pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c52 : 1
stoichiometry:c51 : 1
m22*m29*0.1
nodelay
--

0

PMID: 17535871, 11431423 The TLR2/TLR6 complex is activated by LTA and diacylated lipoproteins, but not by triacylated lipoproteins while the TLR2/TLR1 complex is activated by triacylated lipoproteins, but not by diacylated lipoproteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m21*0.1
nodelay
--

0

PMID: 17535871 Once activated the TIR domain of TLR2 engages with the TIR domain of MyD88 leading to the induction of ¡ÆMyD88-dependent¡Ç genes including TNFa.
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c61 : 1
m6*m19005*m18998*0.1
nodelay
--

0

PMID: 17535871 Like Mal for MyD88, TRAM seems to link TRIF with the intracellular regions of TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c50 : 1
stoichiometry:c53 : 1
stoichiometry:c59 : 1
m23*m26*m28*0.1
nodelay
--

0

PMID: 17535871, 11431423 The TLR2/TLR6 complex is activated by LTA and diacylated lipoproteins, but not by triacylated lipoproteins while the TLR2/TLR1 complex is activated by triacylated lipoproteins, but not by diacylated lipoproteins. PMID: 17535871 LTA from Gram-positive bacteria such as Staphylococcus aureus or diacylated lipoproteins are guided by CD36 to activate the TLR2/TLR6 complex.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c6 : 1
stoichiometry:c5 : 1
m6254*m2828*0.1
nodelay
--

0

PMID: 17535871, 2402637 LBP binds to the amphipathic lipid A moiety of LPS and facilitates its presentation and transfer to CD14.
p20
p20
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m18*m184*0.1
nodelay
--

0

PMID: 17535871 It involves early phase activation of NFkB via the IL-1R-associated kinase (IRAK) pathway.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m32*m183*0.1
nodelay
--

0

PMID: 17535871 It involves early phase activation of NFkB via the IL-1R-associated kinase (IRAK) pathway.
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m34*m33*0.1
nodelay
--

0

PMID: 17535871 It involves early phase activation of NFkB via the IL-1R-associated kinase (IRAK) pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m35*0.1
nodelay
--

0

PMID: 17535871 The TLR-IL-1 receptor (TIR) domains of TLR4 and TRIF or MyD88 are engaged and signalling occurs via the MyD88 or TRIF pathways leading to NOSII or TNF1 respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c78 : 1
m30*0.1
nodelay
--

0

PMID: 17535871 The TLR-IL-1 receptor (TIR) domains of TLR4 and TRIF or MyD88 are engaged and signalling occurs via the MyD88 or TRIF pathways leading to NOSII or TNF1 respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c74 : 1
m6*0.1
nodelay
--

0

PMID: 17535871 LPS induces a plethora of inflammatory and vasoactive genes, including nitric oxide synthase (NOS)II, cyclo-oxygenase-2, endothelin-1, TNF and other cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c75 : 1
m6*0.1
nodelay
--

0

PMID: 17535871 LPS induces a plethora of inflammatory and vasoactive genes, including nitric oxide synthase (NOS)II, cyclo-oxygenase-2, endothelin-1, TNF and other cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c83 : 1
stoichiometry:c82 : 1
m23*m39*m28*0.1
nodelay
--

0

PMID: 17535871, 15690042 for some ligands (LTA and R-MALP2), activation of the TLR2/TLR6 heterodimer is greatly facilitated by CD36.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m41*m4923*0.1
nodelay
--

0

PMID: 17535871, 12796777, 12514169 NOD1 senses diaminopimelic acid (DAP)-containing PepG, which is mainly found in PepG of Gram-negative bacteria, while NOD2 senses the muramyl dipeptide (MDP) present in both Gram-positive and Gram-negative PepG.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m41*m4947*0.1
nodelay
--

0

PMID: 17535871, 12796777, 12514169 NOD1 senses diaminopimelic acid (DAP)-containing PepG, which is mainly found in PepG of Gram-negative bacteria, while NOD2 senses the muramyl dipeptide (MDP) present in both Gram-positive and Gram-negative PepG.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m6255*m5*0.1
nodelay
--

0

PMID: 17535871, 15596121, 16785880 It is believed that MD2 complexes with LPS (provided by CD14) and that the MD2?LPS complex, as apposed to LPS alone, is the ¡Ætrue ligand¡Ç for TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c95 : 1
m42*m2684*0.1
nodelay
--

0

PMID: 17535871 Both NOD1 and NOD2 signal via the adaptor protein RICK (also known as Rip2 or CARDIAK).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c94 : 1
m43*m2684*0.1
nodelay
--

0

PMID: 17535871 Both NOD1 and NOD2 signal via the adaptor protein RICK (also known as Rip2 or CARDIAK).
p32
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m45*m1765*0.1
nodelay
--

0

PMID: 17838971, 15952891, 17186029 The ensuing signalling cascade leads to activation of caspase-1 and the formation of IL-1b and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c99 : 1
m46*0.1
nodelay
--

0

PMID: 17838971, 15952891, 17186029 The ensuing signalling cascade leads to activation of caspase-1 and the formation of IL-1b and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m93364*0.1
nodelay
--

0

PMID: 17838971, 15952891, 17186029 The ensuing signalling cascade leads to activation of caspase-1 and the formation of IL-1b and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m46*0.1
nodelay
--

0

PMID: 17838971, 15952891, 17186029 The ensuing signalling cascade leads to activation of caspase-1 and the formation of IL-1b and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m47*0.1
nodelay
--

0

PMID: 17838971, 15952891, 17186029 The ensuing signalling cascade leads to activation of caspase-1 and the formation of IL-1b and IL-8.
p37
p37
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m18998*m19314*0.1
nodelay
--

0

PMID: 17535871 TLR3 recruits TRIF.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c112 : 1
stoichiometry:c114 : 1
m1572*m14*0.1
nodelay
--

0

PMID: 17535871 TLR7 and TLR8 recruits MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c113 : 1
stoichiometry:c115 : 1
m1572*m15*0.1
nodelay
--

0

PMID: 17535871 TLR7 and TLR8 recruits MyD88.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m3966*m6485*0.1
nodelay
--

0

PMID: 17535871, 11489966, 11323673 TLR5 is a cell surface receptor activated by flagellin, a protein expressed on motile bacteria.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m64*m65*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m64*m69*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c119 : 1
stoichiometry:c121 : 1
m67*m64*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m2254*m64*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m64*m290118*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m64*m73*0.1
nodelay
--

0

PMID: 17535871, 15654120 Examples of endogenous ligands of TLRs are heat shock proteins, hyaluronic acid fragments, soluble heparan sulphate, fibrinogen extra domain A, oxidised LDL and b-defensin 2.
p46
p46
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m3964*m3963*0.1
nodelay
--

0

PMID: 17535871, 16880211, 11095740, 10549626 TLR2 is not thought to act as a monomeric receptor, but heterodimerises with either TLR1 or TLR6 to evoke effects.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m119368*m3965*0.1
nodelay
--

0

PMID: 17535871 TLR3 is an intracellular receptor which is activated by viral double-stranded RNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m13*m19940*0.1
nodelay
--

0

PMID: 17535871 TLR7 and TLR8 are activated by single-stranded RNA from viruses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m13*m19823*0.1
nodelay
--

0

PMID: 17535871 TLR7 and TLR8 are activated by single-stranded RNA from viruses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m16*m19828*0.1
nodelay
--

0

PMID: 17535871, 11130078 TLR9 is activated by bacterial DNA, which because of its high level of unmethylated CpG dinucleotides is distinct from mammalian DNA.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m6*m11*m1572*0.1
nodelay
--

0

PMID: 17535871 TLR4 is unique among the TLRs because it recruits both MyD88/Mal and TRIF/TRAM adaptor proteins.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--